In the six months ending June 30, the company enjoyed revenues of £931,000, compared with £255,000 in the same period last year.
The Trading update says £155,000 came from its £155,000 Microtox instruments and £386,000 from its Qatar project deploying 27 Continuous Toxicity Monitors (CTMs).
In June, the company also launched its Sulphate Reducing Bacteria (SRB) kits.
RECOMMENDED READING:
Bob Moore, Executive Chairman and Chief Executive Officer, Metir plc, said: “The Board is encouraged by the strong sales performance achieved in the first half of 2025 and remains firmly focused on scaling revenue, enhancing gross margins and progressing towards sustainable cash generation.
“Metir is investing prudently in infrastructure and increasing sales and marketing activity to drive future growth. The Group remains committed to increasing our market share and expanding our global footprint across the growing environmental and water testing sectors.
“This includes pursuing major toxic water testing opportunities, similar to the CTM deployment in Qatar, and commercialising our latest innovations.”
